Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 1/2 1

Status

Recruiting 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 2

Conditions

Colorectal Neoplasms 310Squamous Cell Carcinoma of Head and Neck 163Head and Neck Neoplasms 145Carcinoma, Non-Small-Cell Lung 97Colonic Neoplasms 89Rectal Neoplasms 81Neoplasm Metastasis 70Neoplasms 59Pancreatic Neoplasms 40Carcinoma, Squamous Cell 38Lung Neoplasms 35Esophageal Neoplasms 25Breast Neoplasms 22Stomach Neoplasms 20Recurrence 20Laryngeal Neoplasms 17Carcinoma 17Tongue Neoplasms 16Mouth Neoplasms 16Esophageal Squamous Cell Carcinoma 14Oropharyngeal Neoplasms 13Salivary Gland Neoplasms 12Adenocarcinoma Of Esophagus 12Hypopharyngeal Neoplasms 11Laryngeal Diseases 10Adenocarcinoma of Lung 10Uterine Cervical Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 9Ovarian Neoplasms 9Nasopharyngeal Carcinoma 9

Interventions

Gemcitabine 15130-nm albumin-bound paclitaxel 10Albumin-Bound Paclitaxel 7Oxaliplatin 5Paclitaxel 4Leucovorin 4Fluorouracil 4Carboplatin 4Cisplatin 3Cetuximab 3Bevacizumab 3pembrolizumab 2napabucasin 2Pemetrexed 2PEGPH20 2MK-4721 2Irinotecan 2tremelimumab 1selinexor 1relacorilant 1ponatinib 1neratinib 1irinotecan sucrosofate 1folfirinox 1ensituximab 1durvalumab 1contrast agent BR1 1cobimetinib 1ceritinib 1cc-486 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Pancreatic Ductal × Cetuximab × Clear all
NCT06704724 2026-05-22

A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.

Pfizer

Phase 1 Terminated
30 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT06447662 2026-04-20

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

Pfizer

Phase 1 Recruiting
330 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Lung Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

NCT06445062 2026-04-01

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Revolution Medicines, Inc.

Phase 1/2 Recruiting
1,130 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡